Vamvakas, L., Matikas, A., Karampeazis, A., Hatzidaki, D., Kakolyris, S., Christophylakis, C., . . . Souglakos, J. (2014). Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): A multicenter phase II study of the Hellenic Oncology Research Group (HORG). BioMed Central.
Citação norma ChicagoVamvakas, Lambros, et al. Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) As 1st Line Treatment for Fit and Vulnerable Elderly Patients (aged >70 years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG). BioMed Central, 2014.
Citação norma MLAVamvakas, Lambros, et al. Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) As 1st Line Treatment for Fit and Vulnerable Elderly Patients (aged >70 years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG). BioMed Central, 2014.